The pharmaceutical industry is aggressively evolving, with substantial demand for high-quality Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, represents example of this trend. To meet this demand, US-based manufacturing services are stepping forward. These compan